ADAR1 Capital Management »

iShares Lehman Short Treasury Bond shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of iShares Lehman Short Treasury Bond (SHV) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in iShares Lehman Short Treasury Bond

Tip: Access up to 7 years of quarterly data

All positions including iShares Lehman Short Treasury Bond held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares Lehman Short Treasury Bond by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.7M 25k 110.13

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Roivant Sciences SHS (ROIV)
Cytokinetics Com New (CYTK)
Arbutus Biopharma (ABUS)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Cerevel Therapeutics Hldng I (CERE)
Mirati Therapeutics
Merck & Co (MRK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Immunovant (IMVT)
Viking Therapeutics (VKTX)
Protagonist Therapeutics (PTGX)

View all positions for ADAR1 Capital Management

Top funds holding iShares Lehman Short Treasury Bond

Bank of America Corporation
Wells Fargo & Company
Jpmorgan Chase & Co
UBS Group
Betterment
Branch Banking & Trust Company
Royal Bank of Canada
Bank of Nova Scotia
Goldman Sachs Group
Raymond James Financial Services Advisors
Wealth Enhancement Advisory Services
Advisor Group Holdings
Bp Wealth Management
Ausdal Financial Partners
Hansen & Associates Financial Group

View all funds holding iShares Lehman Short Treasury Bond